UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
| | Filed by the Registrant ☒ | | | Filed by a Party other than the Registrant ☐ | |
| | Check the appropriate box: | | |||
| | ☐ | | | Preliminary Proxy Statement | |
| | ☐ | | | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| | ☐ | | | Definitive Proxy Statement | |
| | ☒ | | | Definitive Additional Materials | |
| | ☐ | | | Soliciting Material Pursuant to § 240.14a-12 | |
Inspire Medical Systems, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| | Payment of Filing Fee (Check the appropriate box): | | |||
| | ☒ | | | No fee required. | |
| | ☐ | | | Fee paid previously with preliminary materials. | |
| | ☐ | | | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
